about
Socioeconomic and demographic characteristics of sickle cell disease patients from a low-income region of northeastern BrazilInitial Evaluation of the Pediatric PROMIS® Health Domains in Children and Adolescents With Sickle Cell DiseaseEmerging point-of-care technologies for sickle cell disease screening and monitoring.Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current management of sickle cell anemia.
@en
Current management of sickle cell anemia.
@nl
type
label
Current management of sickle cell anemia.
@en
Current management of sickle cell anemia.
@nl
prefLabel
Current management of sickle cell anemia.
@en
Current management of sickle cell anemia.
@nl
P2093
P2860
P1476
Current management of sickle cell anemia.
@en
P2093
Alecia C Nero
Patrick T McGann
Russell E Ware
P2860
P356
10.1101/CSHPERSPECT.A011817
P577
2013-08-01T00:00:00Z